Pfizer Inc PFE shares are climbing Thursday to a new 52-week high as drugmakers rally broadly. The move comes a week after the FDA approved a Tukysa regimen. Pfizer stock is at critical resistance.
CNN, WLBT, UMCC, PFIZER, KIMBERLY COOLEY, TWITTER, @KMCOOLEY By Katia Hetter, CNN With the Biden administration expected to announce that booster doses will be needed for most people who received the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results